SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 328 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,018,313 | -11.2% | 16,650 | -16.1% | 2.60% | -4.8% |
| Q2 2023 | $2,271,619 | -54.5% | 19,836 | -45.2% | 2.74% | -60.4% |
| Q1 2023 | $4,988,068 | -39.6% | 36,190 | -43.2% | 6.91% | -12.9% |
| Q4 2022 | $8,261,502 | +24.1% | 63,756 | +5.9% | 7.93% | +23.9% |
| Q3 2022 | $6,658,000 | +76.8% | 60,231 | +19.9% | 6.40% | +56.2% |
| Q2 2022 | $3,765,000 | -18.7% | 50,225 | -15.3% | 4.10% | +27.3% |
| Q1 2022 | $4,632,000 | -46.8% | 59,299 | -38.7% | 3.22% | -23.0% |
| Q4 2021 | $8,707,000 | +8.0% | 96,695 | +10.9% | 4.18% | +16.8% |
| Q3 2021 | $8,065,000 | +32.5% | 87,213 | +11.3% | 3.58% | +27.5% |
| Q2 2021 | $6,089,000 | +18.5% | 78,330 | +13.6% | 2.81% | -7.6% |
| Q1 2021 | $5,138,000 | +1.6% | 68,937 | +132.3% | 3.04% | -21.2% |
| Q4 2020 | $5,059,000 | – | 29,672 | – | 3.86% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |